Anthony Radford

Direttore/Membro del Consiglio presso GENETIC SIGNATURES LIMITED

Patrimonio netto: 155 569 $ in data 30/06/2024

Commercial Services

Health Technology

Consumer Services

Posizioni attive di Anthony Radford

Società	Posizione	Inizio	Fine
GENETIC SIGNATURES LIMITED	Direttore/Membro del Consiglio	15/09/2015	-

Storia della carriera di Anthony Radford

Precedenti posizioni note di Anthony Radford

Società	Posizione	Inizio	Fine
Cellestis Pty Ltd. Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.	Direttore/Membro del Consiglio	07/01/2011	01/10/2012
	Amministratore Delegato	28/07/2009	01/10/2012
	Fondatore	01/12/2000	01/10/2012
Amrad Operations Pty Ltd.	Corporate Officer/Principal	01/01/1993	01/12/2000
Commonwealth Scientific & Industrial Research Organisation Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia.	Corporate Officer/Principal	01/10/1985	01/12/1992

Formazione di Anthony Radford

LaTrobe University

Doctorate Degree

Statistiche

Distribuzione geografica

Australia

Posizioni

Director/Board Member	2
Corporate Officer/Principal	2
Chief Executive Officer	1

Settori

Commercial Services	3
Health Technology	2
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	1
GENETIC SIGNATURES LIMITED	Commercial Services

Aziende private	3
Cellestis Pty Ltd. Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.	Health Technology
Commonwealth Scientific & Industrial Research Organisation Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia.	Commercial Services
Amrad Operations Pty Ltd.

Vedi le connessioni aziendali